Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix
Affiliations: Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama 241‑8515, Japan, Bioscience Division, Reagent Development Department, Tosoh Corporation, Ayase, Kanagawa 252‑1123, Japan, Department of Gynecologic Oncology, Kanagawa Cancer Center, Yokohama 241‑8515, Japan, Department of Pathology, Kanagawa Cancer Center, Yokohama 241‑8515, Japan, Department of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama 236‑0004, Japan
- Published online on: January 20, 2021 https://doi.org/10.3892/or.2021.7944
- Pages: 1023-1032
Copyright: © Ota et al. This is an open access article distributed under the terms of Creative Commons Attribution License.